Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc.filedCriticalGenentech, Inc.
Publication of HK1110080ApublicationCriticalpatent/HK1110080A/en
The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such antagonists to treat autoimmune disease in a patient who has failed prior treatment such as treatment with DMARDs or TNFα-inhibitors.
HK08101094.5A2004-12-172005-12-16Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy
HK1110080A
(en)